Friday, March 2, 2012

ACTC stem cells cure blindness

ACTC CEO stated the new patients are doing the same has the 1st two. I think that is why the stock came back from 9 cent and closed at .1015 on 65.7 million shares, the three month avg is 16.9 millions shares. I should have held the shares I brought at .092 longer, but still made a little money.
O.K back to the reverse split, that usually means the company is dying with no products, research or development on the horizon. They reverse split to maintain the appearance of a healthy price per share. If you think ACTC has nothing coming in the future, then do not invest. I feel the Phase 1/2 trials will be successful. It will be a ruff ride, not for scared cats. Always remember you can lose all your money in this company.

Geron closed at $1.94 on 1,235,184 shares the high for the week was $2.15 on Feb 28th the low $1.93 on March 2nd. Wednesday, March 7th at 4:30PM, Geron will host a conference call for analysts and investors. It will be webcast.

No comments:

Post a Comment